Viewing StudyNCT00278915



Ignite Creation Date: 2024-05-05 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00278915
Status: COMPLETED
Last Update Posted: 2024-03-05
First Post: 2006-01-17

Brief Title: Faslodex in McCune-Albright Syndrome
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
McCune-Albright Syndrome
Puberty Precocious
Keywords:
Name View
MAS View
Progressive Precocious Puberty View
PPP View
McCune-Albright Syndrome View